Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Monika Szarszewska
Institution:
Poznan University of Medical Sciences
Observed institution:
Poznan University of Medical Sciences
ORCID:
0000-0002-7101-1909
Observed ORCID:
0000-0002-7101-1909
OpenAlex ID:
A5050435983
ESO-ESSO-ESTRO Multidisciplinary Course in Oncology for Medical Students: 4 Years of Experience (2016–2019)
2021
·
Nicholas Pavlidis
, Radoslaw Madry
, et al.
·
Journal of Cancer Education
·
16
The role of nesfatin and selected molecular factors in various types of endometrial cancer
2019
·
Anna Markowska
, Monika Szarszewska
, et al.
·
Ginekologia Polska
·
11
Significance of BRCA1 expression in breast and ovarian cancer patients with brain metastasis – A multicentre study
2019
·
Monika Szarszewska
, Anna Markowska
, et al.
·
Advances in Medical Sciences
·
10
Metformin in selected malignancies in women
2021
·
Anna Markowska
, Joanna Stanislawiak-Rudowicz
, et al.
·
Ginekologia Polska
·
8
PDF
Thyroid disorders as predictors of cemiplimab efficacy in recurrent/metastatic cervical cancer: real-world evidence from Poland
2025
·
Renata Pacholczak-Madej
, Maja Lisik-Habib
, et al.
·
Frontiers in Immunology
·
5
PDF
Studies on selected molecular factors in endometrial cancers
2018
·
Anna Markowska
, Monika Szarszewska
, et al.
·
Advances in Clinical and Experimental Medicine
·
5
PDF
Expression of selected molecular factors in two types of endometrial cancer
2021
·
Anna Markowska
, Anna Grybos
, et al.
·
Advances in Clinical and Experimental Medicine
·
4
PDF
Effect of metformin on clinical-pathological variables in women with endometrial cancer. A multicenter study
2019
·
Stefan Sajdak
, Anna Markowska
, et al.
·
European Journal of Gynaecological Oncology
·
4
Hypoxia in uterine cervical cancer: impact on treatment
2008
·
Janina Markowska
, Radosław Mądry
, et al.
·
Contemporary Oncology/Współczesna Onkologia
·
2
Plasma total antioxidant status in breast cancer women in relation to lymph node involvement and HER-2/neu expression
2007
·
Miłoslawa Zowczak-Drabarczyk
, Dawid Murawa
, et al.
·
Reports of Practical Oncology & Radiotherapy
·
2
Immune-related adverse events to predict outcomes in recurrent/metastatic cervical cancer treated with cemiplimab: Insights from a rescue access program in Poland.
2025
·
Renata Pacholczak-Madej
, Maja Lisik-Habib
, et al.
·
Journal of Clinical Oncology
·
1
Irisin — a new biomarker for endometrial cancer?
2025
·
Monika Szarszewska
, Janina Markowska
, et al.
·
Ginekologia Polska
·
1
PDF
Immune-Related Adverse Events of Cemiplimab Therapy in Advanced Cervical Cancer—Data from the Polish–Czech Cervical Cancer Immunotherapy Group (PCCIG-01) with a Review of the Literature
2026
·
Radosław Łupkowski
, Karolina Górniak
, et al.
·
Antibodies
Role of nesfatin in endometrial cancers
2019
·
Monika Szarszewska
, Janina Markowska
, et al.
·
Homo Politicus (Academy of Humanities and Economics in Lodz)
Do BRCA 1 mutations affect selected molecular variables in women with breast and ovarian cancer carrying cerebral metastases?
2017
·
Janina Markowska
, Anna Markowska
, et al.
·
Journal of Clinical Oncology
Nesfatyna-1 jako potencjalny marker w raku endometrium i raku jajnika
2016
·
Anna Markowska
, A. Marszalek
, et al.
·
Postepy Biologii Komorki
Show more works
View as search
Works count:
17
Citation count:
72
H-index:
5
I10-index:
3
Year
Topic
Type